Abstract:A tri-block coupling-polymer composed of 4,4'-methylenediphenyl diisocyanate and poly (ethylene oxide) (PEO), abbreviated MPEO, was used as the template surface-modifying additive (SMA), based on which selected amino acids (lysine, arginine, glycin, and aspartic acid) and RGD peptide were respectively conjugated as functional endgroups of the PEO spacer-arms through sulfonyl chloride-activation routes. After the immobilization of biofunctional factors, the SMA-MPEO derivatives were noncovalently introduced onto the biomedical poly(ether urethane) (PEU) surfaces by physical blending methods. The SMA synthesis and PEU surface modification were monitored and analyzed by nuclear magnetic resonance spectroscopy, attenuated total reflection-infrared spectroscopy, and X-ray photoelectron spectroscopy. The human umbilical vein endothelial cells (HUVECs) were collected and harvested manually by collagenase digestion. The cell culture was performed respectively on the MPEO derivative-modified PEU surfaces and also on the surfaces of the commercially available polystyrene cell-culture plates (TCPS) for control. The cell adhesion rates and cell proliferation rates of the in vitro cultivated HUVEC were measured using flow cytometry. The individual cell viability rates were determined with MTT assay. The cell morphologies of the living HUVECs were investigated by optical inverted microscopy, and more detailed information was acquired from scanning electrical microscopy. The results indicated that the efficacy of SMA functional endgroups was the dominant factor for HUVEC compatibility; the proper-sized PEO spacers (M(w) 2 k) could support and mobilize the functional endgroups, optimizing the surface (interface) environment for the cell growth. As the endgroups of the SMA-MPEO derivatives and the bio-functional factors, the basic amino acids (lysine and arginine) demonstrated similar performances to that of the widely acknowledged cell growth-promoter, RGD peptide, which were superior to TCPS. Therefore, these MPEO derivative-modified PEU materials are promising to serve as novel polymeric permanent implants or interventional devices for cardiovascular biomedical applications.

Quantitative Grafting of Peptide Onto the Nontoxic Biodegradable Waterborne Polyurethanes to Fabricate Peptide Modified Scaffold for Soft Tissue Engineering

A novel strategy to graft RGD peptide on biomaterials surfaces for endothelization of small-diamater vascular grafts and tissue engineering blood vessel

Endothelialization of microporous YIGSR/PEG-modified polyurethaneurea

Fabrication and characterization of waterborne biodegradable polyurethanes 3-dimensional porous scaffolds for vascular tissue engineering.

Development of a YIGSR-peptide-modified polyurethaneurea to enhance endothelialization

In Situ Immobilization of Proteins and Rgd Peptide on Polyurethane Surfaces Via Poly(Ethylene Oxide) Coupling Polymers for Human Endothelial Cell Growth

Surface Functionalization of Electrospun Scaffolds by QK-AG73 Peptide for Enhanced Interaction with Vascular Endothelial Cells

Surface Modification of Multiple Bioactive Peptides to Improve Endothelialization of Vascular Grafts

Endothelium Regeneration on Luminal Surface of Polyurethane Vascular Scaffold Modified with Diamine and Covalently Grafted with Gelatin.

Surface Patterning and Modification of Polyurethane Biomaterials Using Silsesquioxane-Gelatin Additives for Improved Endothelial Affinity

Novel Human Endothelial Cell-Engineered Polyurethane Biomaterials for Cardiovascular Biomedical Applications.

Engineering Porous Polyurethane Scaffolds by Photografting Polymerization of Methacrylic Acid for Improved Endothelial Cell Compatibility

Fabrication of PU/PEGMA Crosslinked Hybrid Scaffolds by in Situ UV Photopolymerization Favoring Human Endothelial Cells Growth for Vascular Tissue Engineering.

Development of Multifunctional Peptidomimetic Poly(ester Urethane)urea Scaffolds Loading with Chlorogenic Acid

Biomimetic Polyurethane 3D Scaffolds Based on Polytetrahydrofuran Glycol and Polyethylene Glycol for Soft Tissue Engineering

A Waterborne Polyurethane 3D Scaffold Containing PLGA with a Controllable Degradation Rate and an Anti-Inflammatory Effect for Potential Applications in Neural Tissue Repair.

Synthesis and characterization of RGD peptide grafted poly(ethylene glycol)-b-poly(L-lactide)-b-poly(L-glutamic acid) triblock copolymer.

HPLC detection of loss rate and cell migration of HUVECs in a proanthocyanidin cross-linked recombinant human collagen-peptide (RHC)-chitosan scaffold

Grafting of CAG Peptides and (polyethylene Glycol) on Unsaturated Polyurethane Films to Promote Selective Adhesion and Migration of Urethral Epithelial Cells.

Hydrophilic PCU scaffolds prepared by grafting PEGMA and immobilizing gelatin to enhance cell adhesion and proliferation.

Surface Immobilization of Bioactive Molecules on Polyurethane for Promotion of Cytocompatibility to Human Endothelial Cells